Should ACE Inhibitors Be Used to Slow the Progression of Chronic Renal Diseases?

Author(s):  
Gianluigi Vigan� ◽  
Piero Ruggenenti
2017 ◽  
Vol 01 (01) ◽  
pp. 020-022
Author(s):  
Praveen Vasanthraj ◽  
Varun Bandi ◽  
Venkata Sai ◽  
Manikanthan Shekar

AbstractChronic renal diseases have been on rise with most patients requiring renal transplantation. With advances in treatment, patients undergo hemodialysis through arteriovenous (AV) fistulas and grafts. Thrombosis in these fistulas and grafts are more common and may result in failure. Interventional radiology plays an important role in managing these thromboses through catheter-directed thrombolysis. With success rate of more than 80%, catheter-directed thrombolysis has become the treatment of choice. However, the need of trained personnel, well-equipped catheter laboratories, and expensiveness are its disadvantages. We share our initial experience in two patients in whom we have performed ultrasound-guided percutaneous pulse-spray pharmacomechanical thrombolysis as a day-care procedure. This technique is less expensive, can have a wider outreach, and patients can be benefitted early to avoid new access.


2005 ◽  
Vol 68 ◽  
pp. S21-S24 ◽  
Author(s):  
Norberto Perico ◽  
Igor Codreanu ◽  
Arrigo Schieppati ◽  
Giuseppe Remuzzi

Author(s):  
O. N. Kotenko ◽  
◽  
S. M. Serdyukovskiy ◽  
N. K. Grishina ◽  
А. I. Ibragimov ◽  
...  

2007 ◽  
Vol 11 (1) ◽  
pp. 66-70 ◽  
Author(s):  
Satoru Kuriyama ◽  
Yasushi Otsuka ◽  
Rinako Iida ◽  
Kei Matsumoto ◽  
Tatsuo Hosoya

Sign in / Sign up

Export Citation Format

Share Document